My general framework: Start with semaglutide if cost is a significant concern, or if there is no strong reason to expect poor tolerance Start with tirzepatide if the patient has tried semaglutide before and struggled with side effects, if faster initial response matters clinically, or if the patients goals require larger total weight loss Switch to tirzepatide if a patient on semaglutide is experiencing persistent nausea or has plateaued and escalation options are limited One pattern worth noting: men I see a consistent pattern with male patients who struggle to tolerate semaglutide nausea and GI disruption can be particularly disruptive for them, and theyre often less willing to push through it
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2015;33:67124
Yes, diarrhea is one of the most common side effects of Ozempic
Symptoms of pancreatitis include: Severe abdominal pain that radiates to the back Nausea Vomiting Fever Anyone experiencing these symptoms should stop using the medication and seek medical care immediately
GLP-1 Agonists Weight Loss Drugs Market: Distribution Channel Segment Dashboard 6.2
The FDA has approved Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
